Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour
Citation
Grimpen, F, Yip, D, McArthur, G et al 2005, 'Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour', Lancet Oncology, The, vol. 6, pp. 724-727.Year
2005ANU Authors
Field of Research
- Cancer Therapy (Excl. Chemotherapy And Radiation Therapy)
